This allows the researcher to control the degree of AngII-dependent hypertension and consequent end-organ damage, its speed of attainment and, also, to look at repair processes, once the inducer (indole-3-carbinol; I-3-C) is withdrawn (see ‘Models of diabetic nephropathy’ below). This evidence concerns the gene AGT and Hypertension.